1300017I duke university; task order HHSN27200008-14-0053.A1B1C1D1.0026- a randomized, double-blind, placebo-controlled clinical trial in adults with community acquired pneumonia; base $141,485,…
Ended Awarded Last action
- Contract number
- HHSN27200008
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,990,437
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 77% obligated
-
- $11,990,436.62 Current, with exercised options
- $15,486,126.62 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$134,419 | |
| Funding Only Action | -$52,175 | |
| Supplemental Agreement for work within scope | -$2,387,879 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$1,572 | |
| Exercise an Option | $2,740,223 | |
| Exercise an Option | $2,692,625 | |
| Change Order | $3,711,941 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $364,065 | |
| Original award | $5,057,627 |
Show all 12
About this award
Duke University's Office of Research Administration received a delivery order (HHSN27200008-14-0053.A1B1C1D1.0026) valued at $141,485 in base funding with optional increments totaling $4,916,142 (potential ceiling of $15.5M) from the National Institute of Allergy and Infectious Diseases to conduct a randomized, double-blind, placebo-controlled clinical trial in adults with community-acquired pneumonia. The work is performed under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery vehicle and encompasses an observational study of coccidioidomycosis incidence in patients presenting with community-acquired pneumonia, including evaluation of antifungal treatment outcomes under standard-of-care protocols in endemic areas. The contract is cost-reimbursable with no fee and was awarded on a competitive basis without set-aside designation, with performance scheduled through December 31, 2024.
Duke University engaged three major subcontractors to support trial implementation and enrollment: Saint Louis University (participating in protocol implementation and enrolling 12 subjects), Kaiser Foundation Research Institute (targeting enrollment of 100 community-acquired pneumonia positive subjects to identify 20 with primary pulmonary coccidioidomycosis), and the University of Arizona (implementing protocol 14-0053). These academic and healthcare research institutions collectively provided the clinical infrastructure and patient populations necessary to execute this multisite infectious disease clinical trial, leveraging their expertise in infectious disease research and patient enrollment capabilities to support NIAID's vaccine and treatment evaluation mission.
Description
1300017I duke university; task order HHSN27200008-14-0053.A1B1C1D1.0026- a randomized, double-blind, placebo-controlled clinical trial in adults with community acquired pneumonia; base $141,485, option 1 $67,837, option 2 $4,049,893, and option 4 $798,412
Quick answers
Who was awarded contract HHSN27200008?
HHSN27200008 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 5, 2015.
How much is contract HHSN27200008 worth?
The government has obligated $11,990,437 on HHSN27200008. Its potential value, with all options, is $15,486,127.
Is contract HHSN27200008 an order under another contract?
Yes. HHSN27200008 is a delivery order under HHSN272201300017I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200008 competed?
The extent of competition for HHSN27200008 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award